ad-HER3/C1C2 vaccine (mAbRx)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namead-HER3/C1C2 vaccine (mAbRx)
Drug Alias Nameanti-ZZZ mAb vaccine (mAbRx)mAb therapeutics (mAbRx)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulators
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesmAbRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesmAbRx Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A